Issue of Equity & Total Voting Rights

RNS Number : 2035Z
Mobeus Income & Growth 4 VCT PLC
08 January 2020
 

 

 

Mobeus Income & Growth 4 VCT plc (the "Company")

 

8 January 2020

 

Issue of Equity

 

The Company announces that on 8 January 2020 it allotted and issued 14,967,956 new Ordinary Shares of 1p each ("Shares").  These new Shares in the Company have been issued pursuant to the Offer for subscription with The Income & Growth VCT plc, Mobeus Income & Growth 2 VCT plc and Mobeus Income & Growth 4 VCT plc, launched on 25 October 2019, to raise up to £58 million in aggregate, which includes the utilisation of a £20 million over-allotment facility ("the Offer").

 

In accordance with the allotment formula set out in the prospectus for the Offer, the Shares were issued at prices of between 68.81 and 74.01 pence per Share, depending on the adviser charge (if applicable) and the number of shares issued (after taking roundings into account) pertaining to each application. 

 

Application has been made for the new Ordinary Shares to be admitted to the Official List of the UK Listing Authority and dealings are expected to commence on or around 14 January 2020.

 

Following this allotment, the issued share capital and total voting rights of the Company is 81,767,085 Ordinary Shares of 1p each.

 

Christopher Burke, a director of the Company, was allotted 36,331 Ordinary Shares at a price per share of 68.81 pence and his total holdings are now 36,331, representing approximately 0.04% of the Company's issued Ordinary share capital.

 

The total application figures are updated daily on the VCT section of the Mobeus website at: https://www.mobeus.co.uk/vct-fundraising.

 

For further information please contact:

 

Mobeus Equity Partners LLP,

Company Secretary, on 020 7024 7600.

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFLFLRLTITIII
UK 100

Latest directors dealings